Transient Neonatal Diabetes, ZFP57, and Hypomethylation of Multiple Imprinted Loci: A detailed follow-up

Transient neonatal diabetes mellitus 1 (TNDM1) is the most common cause of diabetes presenting at birth. Approximately 5% of the cases are due to recessive ZFP57 mutations, causing hypomethylation at the TNDM locus and other imprinted loci (HIL). This has consequences for patient care because it has...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2013-03, Vol.36 (3), p.505-512
Hauptverfasser: BOONEN, Susanne E, MACKAY, Deborah J. G, CHI VU, Dũng, BICH NGOC, C. T, BICH NGUYEN, Phuong, KORDONOURI, Olga, SUNDBERG, Frida, DAYANIKLI, Pinar, PUTHI, Vijith, ACERINI, Carlo, MASSOUD, Ahmed F, TÜMER, Zeynep, HAHNEMANN, Johanne M. D, KAREN TEMPLE, I, DOCHERTY, Louise, GRØNSKOV, Karen, LEHMANN, Anna, LARSEN, Lise G, HAEMERS, Andreas P, KOCKAERTS, Yves, DOOMS, Lutgarde
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 512
container_issue 3
container_start_page 505
container_title Diabetes care
container_volume 36
creator BOONEN, Susanne E
MACKAY, Deborah J. G
CHI VU, Dũng
BICH NGOC, C. T
BICH NGUYEN, Phuong
KORDONOURI, Olga
SUNDBERG, Frida
DAYANIKLI, Pinar
PUTHI, Vijith
ACERINI, Carlo
MASSOUD, Ahmed F
TÜMER, Zeynep
HAHNEMANN, Johanne M. D
KAREN TEMPLE, I
DOCHERTY, Louise
GRØNSKOV, Karen
LEHMANN, Anna
LARSEN, Lise G
HAEMERS, Andreas P
KOCKAERTS, Yves
DOOMS, Lutgarde
description Transient neonatal diabetes mellitus 1 (TNDM1) is the most common cause of diabetes presenting at birth. Approximately 5% of the cases are due to recessive ZFP57 mutations, causing hypomethylation at the TNDM locus and other imprinted loci (HIL). This has consequences for patient care because it has impact on the phenotype and recurrence risk for families. We have determined the genotype, phenotype, and epigenotype of the first 10 families to alert health professionals to this newly described genetic subgroup of diabetes. The 10 families (14 homozygous/compound heterozygous individuals) with ZFP57 mutations were ascertained through TNDM1 diagnostic testing. ZFP57 was sequenced in probands and their relatives, and the methylation levels at multiple maternally and paternally imprinted loci were determined. Medical and family histories were obtained, and clinical examination was performed. The key clinical features in probands were transient neonatal diabetes, intrauterine growth retardation, macroglossia, heart defects, and developmental delay. However, the finding of two homozygous relatives without diabetes and normal intelligence showed that the phenotype could be very variable. The epigenotype always included total loss of methylation at the TNDM1 locus and reproducible combinations of differential hypomethylation at other maternally imprinted loci, including tissue mosaicism. There is yet no clear genotype-epigenotype-phenotype correlation to explain the variable clinical presentation, and this results in difficulties predicting the prognosis of affected individuals. However, many cases have a more severe phenotype than seen in other causes of TNDM1. Further cases and global epigenetic testing are needed to clarify this.
doi_str_mv 10.2337/dc12-0700
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3579357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A321579861</galeid><sourcerecordid>A321579861</sourcerecordid><originalsourceid>FETCH-LOGICAL-g282t-7642abf3ffa29782d645e8bcf58b8ba4bfb1fbf61e53d08389bb0771190da1c33</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhi0EotvCgT-ALCGkHhrwRxw7PSCtCqWVlo9DuXCJxom968qxQ-yA9t_jigUKp5FmHr3zvjMIPaPkFeNcvh56yioiCXmAVrTlohKiVg_RitC6rUTbsiN0nNItIaSulXqMjhingjBFVmh3M0NIzoSMP5oYIIPHbx1ok006w18vPwt5hiEM-Go_xdHk3d5DdjHgaPGHxWc3eYOvx2l2IZsBb2LvzvEaDyaD86Vho_fxR7VMT9AjCz6Zp4d6gr5cvru5uKo2n95fX6w31ZYplivZ1Ay05dYCa6ViQ1MLo3RvhdJKQ62tplbbhhrBB6K4arUmUlLakgFoz_kJevNLd1r0aIa-JJvBd8XgCPO-i-C6fyfB7bpt_N5xIcvpZBE4PQjM8dtiUu5Gl3rjPQQTl9RRThmVNROsoC_-Q2_jMocS745SkkrG71Fb8KZzwcayt78T7dac0bJWNbRQz-_7_mP496sK8PIAQOrB2_K33qW_nCQNE63kPwGkI6Cy</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1318717232</pqid></control><display><type>article</type><title>Transient Neonatal Diabetes, ZFP57, and Hypomethylation of Multiple Imprinted Loci: A detailed follow-up</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>BOONEN, Susanne E ; MACKAY, Deborah J. G ; CHI VU, Dũng ; BICH NGOC, C. T ; BICH NGUYEN, Phuong ; KORDONOURI, Olga ; SUNDBERG, Frida ; DAYANIKLI, Pinar ; PUTHI, Vijith ; ACERINI, Carlo ; MASSOUD, Ahmed F ; TÜMER, Zeynep ; HAHNEMANN, Johanne M. D ; KAREN TEMPLE, I ; DOCHERTY, Louise ; GRØNSKOV, Karen ; LEHMANN, Anna ; LARSEN, Lise G ; HAEMERS, Andreas P ; KOCKAERTS, Yves ; DOOMS, Lutgarde</creator><creatorcontrib>BOONEN, Susanne E ; MACKAY, Deborah J. G ; CHI VU, Dũng ; BICH NGOC, C. T ; BICH NGUYEN, Phuong ; KORDONOURI, Olga ; SUNDBERG, Frida ; DAYANIKLI, Pinar ; PUTHI, Vijith ; ACERINI, Carlo ; MASSOUD, Ahmed F ; TÜMER, Zeynep ; HAHNEMANN, Johanne M. D ; KAREN TEMPLE, I ; DOCHERTY, Louise ; GRØNSKOV, Karen ; LEHMANN, Anna ; LARSEN, Lise G ; HAEMERS, Andreas P ; KOCKAERTS, Yves ; DOOMS, Lutgarde</creatorcontrib><description>Transient neonatal diabetes mellitus 1 (TNDM1) is the most common cause of diabetes presenting at birth. Approximately 5% of the cases are due to recessive ZFP57 mutations, causing hypomethylation at the TNDM locus and other imprinted loci (HIL). This has consequences for patient care because it has impact on the phenotype and recurrence risk for families. We have determined the genotype, phenotype, and epigenotype of the first 10 families to alert health professionals to this newly described genetic subgroup of diabetes. The 10 families (14 homozygous/compound heterozygous individuals) with ZFP57 mutations were ascertained through TNDM1 diagnostic testing. ZFP57 was sequenced in probands and their relatives, and the methylation levels at multiple maternally and paternally imprinted loci were determined. Medical and family histories were obtained, and clinical examination was performed. The key clinical features in probands were transient neonatal diabetes, intrauterine growth retardation, macroglossia, heart defects, and developmental delay. However, the finding of two homozygous relatives without diabetes and normal intelligence showed that the phenotype could be very variable. The epigenotype always included total loss of methylation at the TNDM1 locus and reproducible combinations of differential hypomethylation at other maternally imprinted loci, including tissue mosaicism. There is yet no clear genotype-epigenotype-phenotype correlation to explain the variable clinical presentation, and this results in difficulties predicting the prognosis of affected individuals. However, many cases have a more severe phenotype than seen in other causes of TNDM1. Further cases and global epigenetic testing are needed to clarify this.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc12-0700</identifier><identifier>PMID: 23150280</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Biological and medical sciences ; Causes of ; Deoxyribonucleic acid ; Development and progression ; Diabetes Mellitus, Type 1 - genetics ; Diabetes. Impaired glucose tolerance ; DNA ; DNA methylation ; DNA Methylation - genetics ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Gene expression ; Genetic aspects ; Genetic Predisposition to Disease - genetics ; Genomic Imprinting - genetics ; Genotype ; Humans ; Infant, Newborn ; Infant, Newborn, Diseases ; Medical sciences ; Metabolic diseases ; Methylation ; Miscellaneous ; Mutation ; Original Research ; Phenotype ; Physiological aspects ; Proteins ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Stem cells ; Studies ; Type 1 diabetes</subject><ispartof>Diabetes care, 2013-03, Vol.36 (3), p.505-512</ispartof><rights>2014 INIST-CNRS</rights><rights>COPYRIGHT 2013 American Diabetes Association</rights><rights>Copyright American Diabetes Association Mar 2013</rights><rights>2013 by the American Diabetes Association. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27062597$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23150280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BOONEN, Susanne E</creatorcontrib><creatorcontrib>MACKAY, Deborah J. G</creatorcontrib><creatorcontrib>CHI VU, Dũng</creatorcontrib><creatorcontrib>BICH NGOC, C. T</creatorcontrib><creatorcontrib>BICH NGUYEN, Phuong</creatorcontrib><creatorcontrib>KORDONOURI, Olga</creatorcontrib><creatorcontrib>SUNDBERG, Frida</creatorcontrib><creatorcontrib>DAYANIKLI, Pinar</creatorcontrib><creatorcontrib>PUTHI, Vijith</creatorcontrib><creatorcontrib>ACERINI, Carlo</creatorcontrib><creatorcontrib>MASSOUD, Ahmed F</creatorcontrib><creatorcontrib>TÜMER, Zeynep</creatorcontrib><creatorcontrib>HAHNEMANN, Johanne M. D</creatorcontrib><creatorcontrib>KAREN TEMPLE, I</creatorcontrib><creatorcontrib>DOCHERTY, Louise</creatorcontrib><creatorcontrib>GRØNSKOV, Karen</creatorcontrib><creatorcontrib>LEHMANN, Anna</creatorcontrib><creatorcontrib>LARSEN, Lise G</creatorcontrib><creatorcontrib>HAEMERS, Andreas P</creatorcontrib><creatorcontrib>KOCKAERTS, Yves</creatorcontrib><creatorcontrib>DOOMS, Lutgarde</creatorcontrib><title>Transient Neonatal Diabetes, ZFP57, and Hypomethylation of Multiple Imprinted Loci: A detailed follow-up</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>Transient neonatal diabetes mellitus 1 (TNDM1) is the most common cause of diabetes presenting at birth. Approximately 5% of the cases are due to recessive ZFP57 mutations, causing hypomethylation at the TNDM locus and other imprinted loci (HIL). This has consequences for patient care because it has impact on the phenotype and recurrence risk for families. We have determined the genotype, phenotype, and epigenotype of the first 10 families to alert health professionals to this newly described genetic subgroup of diabetes. The 10 families (14 homozygous/compound heterozygous individuals) with ZFP57 mutations were ascertained through TNDM1 diagnostic testing. ZFP57 was sequenced in probands and their relatives, and the methylation levels at multiple maternally and paternally imprinted loci were determined. Medical and family histories were obtained, and clinical examination was performed. The key clinical features in probands were transient neonatal diabetes, intrauterine growth retardation, macroglossia, heart defects, and developmental delay. However, the finding of two homozygous relatives without diabetes and normal intelligence showed that the phenotype could be very variable. The epigenotype always included total loss of methylation at the TNDM1 locus and reproducible combinations of differential hypomethylation at other maternally imprinted loci, including tissue mosaicism. There is yet no clear genotype-epigenotype-phenotype correlation to explain the variable clinical presentation, and this results in difficulties predicting the prognosis of affected individuals. However, many cases have a more severe phenotype than seen in other causes of TNDM1. Further cases and global epigenetic testing are needed to clarify this.</description><subject>Biological and medical sciences</subject><subject>Causes of</subject><subject>Deoxyribonucleic acid</subject><subject>Development and progression</subject><subject>Diabetes Mellitus, Type 1 - genetics</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>DNA</subject><subject>DNA methylation</subject><subject>DNA Methylation - genetics</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Gene expression</subject><subject>Genetic aspects</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genomic Imprinting - genetics</subject><subject>Genotype</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infant, Newborn, Diseases</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Methylation</subject><subject>Miscellaneous</subject><subject>Mutation</subject><subject>Original Research</subject><subject>Phenotype</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Stem cells</subject><subject>Studies</subject><subject>Type 1 diabetes</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU1v1DAQhi0EotvCgT-ALCGkHhrwRxw7PSCtCqWVlo9DuXCJxom968qxQ-yA9t_jigUKp5FmHr3zvjMIPaPkFeNcvh56yioiCXmAVrTlohKiVg_RitC6rUTbsiN0nNItIaSulXqMjhingjBFVmh3M0NIzoSMP5oYIIPHbx1ok006w18vPwt5hiEM-Go_xdHk3d5DdjHgaPGHxWc3eYOvx2l2IZsBb2LvzvEaDyaD86Vho_fxR7VMT9AjCz6Zp4d6gr5cvru5uKo2n95fX6w31ZYplivZ1Ay05dYCa6ViQ1MLo3RvhdJKQ62tplbbhhrBB6K4arUmUlLakgFoz_kJevNLd1r0aIa-JJvBd8XgCPO-i-C6fyfB7bpt_N5xIcvpZBE4PQjM8dtiUu5Gl3rjPQQTl9RRThmVNROsoC_-Q2_jMocS745SkkrG71Fb8KZzwcayt78T7dac0bJWNbRQz-_7_mP496sK8PIAQOrB2_K33qW_nCQNE63kPwGkI6Cy</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>BOONEN, Susanne E</creator><creator>MACKAY, Deborah J. G</creator><creator>CHI VU, Dũng</creator><creator>BICH NGOC, C. T</creator><creator>BICH NGUYEN, Phuong</creator><creator>KORDONOURI, Olga</creator><creator>SUNDBERG, Frida</creator><creator>DAYANIKLI, Pinar</creator><creator>PUTHI, Vijith</creator><creator>ACERINI, Carlo</creator><creator>MASSOUD, Ahmed F</creator><creator>TÜMER, Zeynep</creator><creator>HAHNEMANN, Johanne M. D</creator><creator>KAREN TEMPLE, I</creator><creator>DOCHERTY, Louise</creator><creator>GRØNSKOV, Karen</creator><creator>LEHMANN, Anna</creator><creator>LARSEN, Lise G</creator><creator>HAEMERS, Andreas P</creator><creator>KOCKAERTS, Yves</creator><creator>DOOMS, Lutgarde</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130301</creationdate><title>Transient Neonatal Diabetes, ZFP57, and Hypomethylation of Multiple Imprinted Loci: A detailed follow-up</title><author>BOONEN, Susanne E ; MACKAY, Deborah J. G ; CHI VU, Dũng ; BICH NGOC, C. T ; BICH NGUYEN, Phuong ; KORDONOURI, Olga ; SUNDBERG, Frida ; DAYANIKLI, Pinar ; PUTHI, Vijith ; ACERINI, Carlo ; MASSOUD, Ahmed F ; TÜMER, Zeynep ; HAHNEMANN, Johanne M. D ; KAREN TEMPLE, I ; DOCHERTY, Louise ; GRØNSKOV, Karen ; LEHMANN, Anna ; LARSEN, Lise G ; HAEMERS, Andreas P ; KOCKAERTS, Yves ; DOOMS, Lutgarde</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g282t-7642abf3ffa29782d645e8bcf58b8ba4bfb1fbf61e53d08389bb0771190da1c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biological and medical sciences</topic><topic>Causes of</topic><topic>Deoxyribonucleic acid</topic><topic>Development and progression</topic><topic>Diabetes Mellitus, Type 1 - genetics</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>DNA</topic><topic>DNA methylation</topic><topic>DNA Methylation - genetics</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Gene expression</topic><topic>Genetic aspects</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genomic Imprinting - genetics</topic><topic>Genotype</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infant, Newborn, Diseases</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Methylation</topic><topic>Miscellaneous</topic><topic>Mutation</topic><topic>Original Research</topic><topic>Phenotype</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Stem cells</topic><topic>Studies</topic><topic>Type 1 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BOONEN, Susanne E</creatorcontrib><creatorcontrib>MACKAY, Deborah J. G</creatorcontrib><creatorcontrib>CHI VU, Dũng</creatorcontrib><creatorcontrib>BICH NGOC, C. T</creatorcontrib><creatorcontrib>BICH NGUYEN, Phuong</creatorcontrib><creatorcontrib>KORDONOURI, Olga</creatorcontrib><creatorcontrib>SUNDBERG, Frida</creatorcontrib><creatorcontrib>DAYANIKLI, Pinar</creatorcontrib><creatorcontrib>PUTHI, Vijith</creatorcontrib><creatorcontrib>ACERINI, Carlo</creatorcontrib><creatorcontrib>MASSOUD, Ahmed F</creatorcontrib><creatorcontrib>TÜMER, Zeynep</creatorcontrib><creatorcontrib>HAHNEMANN, Johanne M. D</creatorcontrib><creatorcontrib>KAREN TEMPLE, I</creatorcontrib><creatorcontrib>DOCHERTY, Louise</creatorcontrib><creatorcontrib>GRØNSKOV, Karen</creatorcontrib><creatorcontrib>LEHMANN, Anna</creatorcontrib><creatorcontrib>LARSEN, Lise G</creatorcontrib><creatorcontrib>HAEMERS, Andreas P</creatorcontrib><creatorcontrib>KOCKAERTS, Yves</creatorcontrib><creatorcontrib>DOOMS, Lutgarde</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BOONEN, Susanne E</au><au>MACKAY, Deborah J. G</au><au>CHI VU, Dũng</au><au>BICH NGOC, C. T</au><au>BICH NGUYEN, Phuong</au><au>KORDONOURI, Olga</au><au>SUNDBERG, Frida</au><au>DAYANIKLI, Pinar</au><au>PUTHI, Vijith</au><au>ACERINI, Carlo</au><au>MASSOUD, Ahmed F</au><au>TÜMER, Zeynep</au><au>HAHNEMANN, Johanne M. D</au><au>KAREN TEMPLE, I</au><au>DOCHERTY, Louise</au><au>GRØNSKOV, Karen</au><au>LEHMANN, Anna</au><au>LARSEN, Lise G</au><au>HAEMERS, Andreas P</au><au>KOCKAERTS, Yves</au><au>DOOMS, Lutgarde</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transient Neonatal Diabetes, ZFP57, and Hypomethylation of Multiple Imprinted Loci: A detailed follow-up</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>36</volume><issue>3</issue><spage>505</spage><epage>512</epage><pages>505-512</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>Transient neonatal diabetes mellitus 1 (TNDM1) is the most common cause of diabetes presenting at birth. Approximately 5% of the cases are due to recessive ZFP57 mutations, causing hypomethylation at the TNDM locus and other imprinted loci (HIL). This has consequences for patient care because it has impact on the phenotype and recurrence risk for families. We have determined the genotype, phenotype, and epigenotype of the first 10 families to alert health professionals to this newly described genetic subgroup of diabetes. The 10 families (14 homozygous/compound heterozygous individuals) with ZFP57 mutations were ascertained through TNDM1 diagnostic testing. ZFP57 was sequenced in probands and their relatives, and the methylation levels at multiple maternally and paternally imprinted loci were determined. Medical and family histories were obtained, and clinical examination was performed. The key clinical features in probands were transient neonatal diabetes, intrauterine growth retardation, macroglossia, heart defects, and developmental delay. However, the finding of two homozygous relatives without diabetes and normal intelligence showed that the phenotype could be very variable. The epigenotype always included total loss of methylation at the TNDM1 locus and reproducible combinations of differential hypomethylation at other maternally imprinted loci, including tissue mosaicism. There is yet no clear genotype-epigenotype-phenotype correlation to explain the variable clinical presentation, and this results in difficulties predicting the prognosis of affected individuals. However, many cases have a more severe phenotype than seen in other causes of TNDM1. Further cases and global epigenetic testing are needed to clarify this.</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>23150280</pmid><doi>10.2337/dc12-0700</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2013-03, Vol.36 (3), p.505-512
issn 0149-5992
1935-5548
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3579357
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete
subjects Biological and medical sciences
Causes of
Deoxyribonucleic acid
Development and progression
Diabetes Mellitus, Type 1 - genetics
Diabetes. Impaired glucose tolerance
DNA
DNA methylation
DNA Methylation - genetics
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Gene expression
Genetic aspects
Genetic Predisposition to Disease - genetics
Genomic Imprinting - genetics
Genotype
Humans
Infant, Newborn
Infant, Newborn, Diseases
Medical sciences
Metabolic diseases
Methylation
Miscellaneous
Mutation
Original Research
Phenotype
Physiological aspects
Proteins
Public health. Hygiene
Public health. Hygiene-occupational medicine
Stem cells
Studies
Type 1 diabetes
title Transient Neonatal Diabetes, ZFP57, and Hypomethylation of Multiple Imprinted Loci: A detailed follow-up
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T00%3A57%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transient%20Neonatal%20Diabetes,%20ZFP57,%20and%20Hypomethylation%20of%20Multiple%20Imprinted%20Loci:%20A%20detailed%20follow-up&rft.jtitle=Diabetes%20care&rft.au=BOONEN,%20Susanne%20E&rft.date=2013-03-01&rft.volume=36&rft.issue=3&rft.spage=505&rft.epage=512&rft.pages=505-512&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/dc12-0700&rft_dat=%3Cgale_pubme%3EA321579861%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1318717232&rft_id=info:pmid/23150280&rft_galeid=A321579861&rfr_iscdi=true